209 related articles for article (PubMed ID: 12865927)
1. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
[TBL] [Abstract][Full Text] [Related]
2. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
[TBL] [Abstract][Full Text] [Related]
3. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
4. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
[TBL] [Abstract][Full Text] [Related]
7. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
[TBL] [Abstract][Full Text] [Related]
11. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
14. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
17. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M
Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]